MARKET NEWS

 

Cocrystal Pharma Initiates Enrollment in Phase 1 Influenza A Study
Pharmazz Announces FDA Clearance of an IND Application for Phase 2 Clinical Trial
Denali Therapeutics Announces Initiation of Phase 1/2 Clinical Trial
Vibalogics Completes Major Milestone in $50-Million Facility Expansion
Atossa Therapeutics Announces Issuance of Key US Patent Covering Endoxifen
Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate

  FEATURED EDITORIAL

  COMPANY PROFILE

Micropore Technologies is a global process technology and service provider to the pharmaceutical industry featuring patented crossflow mixing equipment for the commercially scalable development of microspheres, nanoparticles, and emulsions used in a wide range of controlled release, sterile injectable drug products. Originally spun-out of Loughborough University’s internationally renowned chemical engineering department, the company’s global headquarters and technical center are located in Wilton Center, UK with offices and operations in the USA, India, South Korea & Japan supporting over a hundred clients and strategic partners. Click here for more.

Lyophilization Technology, Inc. (LTI) is a Contract Development & Manufacturing Organization (CDMO) focused on all aspects of lyophilization for preparation of health care products. Clients leverage on our abilities for bringing new products to the clinic and implementing improvements for current products. Capitalize on over 25 years of excellence and our unparalleled capabilities in product development, process engineering, clinical manufacturing, and technical support. Click here for more.

  EXCLUSIVE ONLINE CONTENT

 

Evonik Launches New Technology to Improve Solubility of Oral Small Molecules

Evonik Launches New Technology to Improve Solubility of Oral Small Molecules

Evonik recently announced it now offers EUDRATEC SoluFlow, a new microparticle technology to enhance solubility of active pharmaceutical ingredients in oral drug products…..

Novartis, Voyager Therapeutics Reach License Option Agreement

Novartis, Voyager Therapeutics Reach License Option Agreement

Novartis recently announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three….

Adaptive Research & UBERDOC Announce Collaboration

Adaptive Research & UBERDOC Announce Collaboration

Adaptive Research and UBERDOC recently announced a collaboration to expand clinical trial access to the physicians and clinical trial sites….

Targovax ASA & Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted With QS-21 STIMULON

Targovax ASA & Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted With QS-21 STIMULON

Agenus and Targovax ASA recently announced they have entered into a clinical collaboration and supply agreement to combine Targovax’s TG mutant KRAS cancer vaccines with Agenus´s clinically validated….

  WHITEPAPERS & WEBINARS

WEBINAR: BPOG 2020 & USP 665 – Extractables Testing of Single-Use Systems

WEBINAR: BPOG 2020 & USP 665 – Extractables Testing of Single-Use Systems

This webinar will explore how to conduct effective extractables and leachables (E&L) testing on plastic process materials used during pharmaceutical and biopharmaceutical manufacturing…..

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

Emergent and groniger partner to present the benefits and features of the INTEGRA® high-speed aseptic fill line with isolator technology for viral vaccines and therapeutics.

WEBINAR - ILC Dover: Handling Potent Products in a Sterile Environment

WEBINAR - ILC Dover: Handling Potent Products in a Sterile Environment

The need for flexible solutions for potent product handling is increasing. We’ll discuss the proven benefits of aseptic isolator systems in sterile environments and take a look at real feedback from real customers of ours in an upcoming webinar on Tuesday, November 16th at 11:00 AM EST.

  WHITEPAPERS & WEBINARS

WHITE PAPER: HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity

WHITE PAPER: HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity

What techniques should manufacturers employ when working with low-dose drug products?

By: Thomas Daggs, MBA, Vice President, Product Development & Quality Control, and Angelo Consalvo, Director of Manufacturing, Enteris BioPharma

Anyone who takes an oral tablet medication – whether prescribed …

eBOOK: Antibody Production

eBOOK: Antibody Production

Antibody production is a multi-step complex process and generating reproducible antibodies is highly critical for immunoassays-based research, immunodiagnostics, and immunotherapy. Antibodies’ reproducibility is driven by their specificity and several other factors ranging from antibody design to target validation. Our Antibody …

WHITE PAPER - A Safe & Efficient Analytical Method for Identity Determination of Oligonucleotides is Now Available     

WHITE PAPER - A Safe & Efficient Analytical Method for Identity Determination of Oligonucleotides is Now Available     

By: Alexandra H. Heussner, PhD, Laboratory Manager ASL, and Melanie Zerulla-Wernitz, PhD, Head of ASL, Development Service, Vetter Pharma-Fertigung GmbH & Co. KG

In the pharmaceutical manufacturing process, a relatively new class of parenteral drug products on the market – …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 23 – Parenteral Contract Manufacturing
March 30 – Polymers & Biomaterials